Literature DB >> 17354188

The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy.

Mehmet Halit Yilmaz1, Gül Esen, Yasemin Ayarcan, Fatih Aydoğan, Mustafa Ozgüroğlu, Gökhan Demir, Nuran Beşe, Nil Molinas Mandel.   

Abstract

PURPOSE: To determine the role of clinical examination, ultrasonography (US), and magnetic resonance imaging (MRI) in detecting local tumor recurrence in patients who underwent modified radical mastectomy for breast cancer.
MATERIALS AND METHODS: The study included 27 patients who were examined between April 1999 and April 2003. US evaluation of the chest wall was performed in all patients. MRI was performed on 10 patients due to suspicious findings in clinical examination, on 3 patients due to US findings, and on 8 patients due to both US and clinical examination findings. Six patients without any suspicious findings underwent MRI for follow-up purposes. The lesions detected with MRI were evaluated according to their morphology, contrast enhancement characteristics and dynamics. The focal lesions that enhanced intensely at the early phase were accepted as suspicious for malignancy.
RESULTS: Of the 10 cases that underwent biopsy secondary to suspicious lesions for malignancy according to MRI findings, 7 were found to have recurrence. In the remaining 3 patients, recurrence diagnosis was made based on the fact that the lesions regressed in response to chemotherapy. In 17 cases, there were no suspicious findings on MRI for local recurrence. In 2 of these cases, biopsies were performed due to suspicious US findings; however, no malignancies were detected. The sensitivity and specificity of clinical examination in detecting local recurrence was 70% and 35.2%, respectively. These values were 90% and 88.2% for US, and 100% and 100% for MRI.
CONCLUSION: In patients with mastectomy, US and MRI were more successful in detecting local recurrence than clinical examination. Considering the fact that US is cheaper and more readily available than MRI, it should be part of the routine follow-up in order to detect local recurrence early. MRI will be helpful in cases with suspicious US findings by increasing the specificity of the evaluation as well as determining the actual size and spread of any lesions, which is valuable information for the subsequent management and response to the particular treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17354188

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  6 in total

1.  FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.

Authors:  LingLing Pan; Yuan Han; XiaoGuang Sun; JianJun Liu; Huang Gang
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-21       Impact factor: 4.553

2.  The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines.

Authors:  Laura S Gold; Gregory Klein; Lauren Carr; Larry Kessler; Sean D Sullivan
Journal:  Cancer Imaging       Date:  2012-01-25       Impact factor: 3.909

3.  Palpable Lumps after Mastectomy: Radiologic-Pathologic Review of Benign and Malignant Masses.

Authors:  Rend Al-Khalili; Ali Alzeer; Giang-Kimthi Nguyen; Erin P Crane; Judy H Song; Janice L Jeon; Michael Nellamattathil; Erini V Makariou; Victoria L Mango
Journal:  Radiographics       Date:  2021-05-14       Impact factor: 6.312

4.  Ultrasonographic features of traumatic neuromas in breast cancer patients after mastectomy.

Authors:  Hwa Sung Sung; Young-Seon Kim
Journal:  Ultrasonography       Date:  2016-07-18

Review 5.  Traumatic neuroma in mastectomy scar: Two case reports and review of the literature.

Authors:  Wenyi Chen; Huan Zhang; Jiayan Huang; Yixuan Li; Zhang Zhang; Yulan Peng
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 6.  Anthropometric Measurements Usage in Medical Sciences.

Authors:  Nevin Utkualp; Ilker Ercan
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.